IMARC Group, a leading global market research and management consulting firm, has published its latest market intelligence report on the white biotechnology market. The global white biotechnology market size was valued at USD 375.6 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 821.4 Billion by 2034, exhibiting a CAGR of 9.08% from 2026-2034, with North America dominating the market at over 44.7% share. The market is driven by robust investments in research and development, strong industrial infrastructure, and growing demand for sustainable bio-based products across diverse industries.
Consolidation and platform-building continue to reshape the industrial enzyme and microbial solutions space. Novonesis, formed through the merger of Novozymes and Chr. Hansen, holds an estimated 48% share of the global industrial enzyme market and reported a broader platform revenue of around DKK 31.5 Billion, having previously paid EUR 1.5 Billion for DSM's enzyme assets and continuing to pursue bolt-on acquisitions such as TurtleTree. Biofuels remain the largest product segment at around 37.5% share, while bioenergy leads applications at around 38.1% share, underscoring how renewable-energy demand continues to anchor the broader white biotechnology market.
White Biotechnology Market at a Glance
Market Size: USD 375.6 Billion
Forecast Size 2034: USD 821.4 Billion
Growth Rate 2026-2034: CAGR of 9.08%Leading Product: Biofuels, approximately 37.5% share
Leading Application: Bioenergy, approximately 38.1% share
Dominant Region: North America, over 44.7% revenue share
United States Share of North America: approximately 86.90%
Leading Enzyme Player Global Share: Novonesis, approximately 48% of the industrial enzyme market
How AI is Reshaping the White Biotechnology Market
AI-Accelerated Enzyme Engineering: Researchers from BASF, the Austrian Research Centre of Industrial Biotechnology, and the University of Graz co-developed a computer-assisted model designed to enhance enzyme efficiency, aimed at accelerating how new biocatalytic processes move from laboratory testing to full production lines.
AI-Driven Strain Development at Scale: India's newly inaugurated DBT-ICGEB Biofoundry in New Delhi uses Design-Build-Test-Learn workflows, bio-automation, and artificial intelligence to compress microbial strain development timelines, aiming to bridge the gap between laboratory science and industrial-scale biomanufacturing.
AI-Enabled Bioprocess Optimization: Ongoing advancements in bioprocess optimization and genetic engineering, supported by data science and machine learning tools under frameworks such as India's BioE3 Policy, are being used to fine-tune fermentation conditions and improve yield efficiency across biobased chemical and enzyme production.
Grab a sample copy of this report: https://www.imarcgroup.com/white-biotechnology-market/requestsample
White Biotechnology Market Trends and Drivers
Environmental pressure remains the foundational demand driver. The World Health Organization estimates that air pollution causes around seven million deaths worldwide each year, with nine out of ten people breathing air containing unsafe pollutant levels, a backdrop that continues to push industries toward biological production systems that reduce carbon impact and industrial waste.
Government policy support is compounding this shift. The International Energy Agency projects that global renewable energy consumption across power, heating, and transport could rise by nearly 60% between 2024 and 2030, while the European Union's Circular Biobased Europe Joint Undertaking, a EUR 2 Billion partnership between the EU and the Bio-based Industries Consortium, announced EUR 170.7 Million in fresh calls to accelerate bio-based solutions.
Capital formation across synthetic biology and industrial biomanufacturing has strengthened materially. Venture investment into synthetic biology reached USD 12.2 Billion in a recent year, up from USD 10.7 Billion previously, while the U.S. Department of Defense has committed USD 1 Billion over five years toward domestic bioindustrial manufacturing infrastructure, a signal that is de-risking fermentation and biomanufacturing capacity build-out across the American market.
Global Regulatory, Trade, and Sustainability Landscape Shaping Demand
Carbon Reduction and Emissions Compliance: Strict environmental regulations, particularly across Europe, are pushing industries toward bio-based production methods that lower greenhouse gas emissions and industrial waste, aligning corporate sustainability commitments with regulatory compliance requirements.
Bioeconomy Strategy Realignment: China's successive Five-Year Plans have set explicit development targets for biotechnology and the bioeconomy, aiming to raise the share of bio-based products in industrial value added, while the European Commission has presented a renewed bioeconomy strategy responding to competitive pressure from the United States and China.
Defense and Supply Chain Resilience Mandates: The U.S. Department of Defense's biomanufacturing investment programme is explicitly framed around reducing supply chain fragility for mission-critical materials, folding industrial biotechnology into national security policy rather than treating it purely as a commercial category.
Circular Economy and Waste Utilization Rules: Growing regulatory emphasis on circular economy practices is encouraging industries to adopt bio-based production and recycling processes, exemplified by companies expanding microorganism- and enzyme-based recycling technologies to meet tightening waste-reduction standards.
Key Government Schemes and Policy Programs Supporting the Industry
India, BioE3 Policy for High-Performance Biomanufacturing: India's Union Cabinet approved the BioE3 (Biotechnology for Economy, Environment and Employment) Policy, the country's first dedicated national biotechnology policy, targeting six thematic sectors including bio-based chemicals and enzymes, with a companion Bio-RIDE scheme carrying a proposed outlay of INR 9,197 Crore and eleven calls for proposals already announced across the policy's thematic areas.
United States, Department of Defense Biomanufacturing Investment: The U.S. Department of Defense has committed USD 1 Billion over five years toward domestic bioindustrial manufacturing infrastructure, building on earlier biomanufacturing investment announcements aimed at strengthening fermentation and scale-up capacity for mission-critical bio-based materials.
European Union, Circular Biobased Europe Joint Undertaking: The EU's Circular Biobased Europe Joint Undertaking, a EUR 2 Billion partnership between the European Commission and the Bio-based Industries Consortium, issued EUR 170.7 Million in new funding calls to accelerate bio-based industrial solutions, alongside Horizon Europe's broader research and innovation funding for biotechnology.
Germany, Federal Ministry for Education and Research Grants: Germany's Federal Ministry for Education and Research backed BASF's FUMBIO project with EUR 2.6 Million in funding to develop bio-based fumaric acid production using bacterial fermentation, aimed at reducing the carbon footprint of chemical manufacturing.
China, Five-Year Plan Bio-Economy Targets: China's successive Five-Year Plans have set explicit development priorities for biotechnology and the bioeconomy aimed at raising the share of bio-based products in industrial output, with the current plan emphasizing original innovation and technological independence in biotechnology.
White Biotechnology Industry Segmentation
The report has segmented the market into the following categories:
Breakup By Product:
Biofuels
Biochemicals
Biopolymers
Biofuels stand as the largest product segment at around 37.5% share, produced from biological feedstocks such as plant materials, algae, and waste, offering a lower-emission replacement for fossil fuels. Advances in enzymatic hydrolysis and microbial fermentation have made biofuel production progressively cheaper and more efficient, reinforcing this segment's lead.
Breakup By Application:
Bioenergy
Food and Feed Additives
Pharmaceutical Ingredients
Personal Care and Household Products
Others
Bioenergy leads applications at around 38.1% share, drawing on biomass, agricultural residue, and biochemical processes such as fermentation and anaerobic digestion to produce biogas, bioethanol, and biodiesel, directly displacing fossil fuel use across the energy sector.
Breakup By Region:
North America
Asia Pacific
Europe
Latin America
Middle East and Africa
North America leads with over 44.7% share, anchored by the United States at approximately 86.90% of regional revenue, supported by strong public and private R&D investment, an established research infrastructure, and close collaboration between academic institutions and industry.
Competitive Landscape
The competitive landscape of the white biotechnology market is shaped by intense R&D investment, strategic partnerships, and active consolidation among enzyme and microbial solutions providers. Companies profiled in the report include:
Archer Daniels Midland Company
BASF SE
Cargill Inc.
DuPont de Nemours Inc.
Fujifilm Holdings Corporation
Henkel AG & Co. KGaA
Kaneka Corporation
Koninklijke DSM N.V.
Lonza Group AG
Mitsubishi Corporation
Novozymes A/S
Consolidation at the top of the enzyme value chain has accelerated, with Novonesis, the combined Novozymes and Chr. Hansen platform, having paid EUR 1.5 Billion for DSM's enzyme assets and holding an estimated 48% share of the global industrial enzyme market. BASF has since moved to divest its own feed enzyme business, a division reported in the USD 150 to 200 Million range, with Novonesis, Cargill, and Asian feed manufacturers cited as the most likely acquirers, reflecting how scale and specialization increasingly define competitive positioning in industrial enzymes.
Market Concentration Analysis
Enzyme Platform Consolidation: The Novonesis merger, combined with its subsequent acquisition of DSM's enzyme assets, has concentrated close to half of the global industrial enzyme market in a single platform, pushing remaining players such as BASF to reconsider ownership of non-core enzyme businesses.
Chemical Majors Rebalancing Toward Core Integration: BASF's decision to seek buyers for its feed enzyme unit signals that large diversified chemical conglomerates see limited integration benefit in fermentation-derived biologicals relative to focused biosolutions specialists.
Government-Backed Infrastructure as a Competitive Differentiator: Public biomanufacturing infrastructure, from India's Biofoundry network to the U.S. Department of Defense's domestic manufacturing investment, is becoming a structural advantage for national industries seeking to scale bio-based production independent of private capital cycles alone.
Recent News and Developments in the White Biotechnology Market
April 2026: India's Department of Biotechnology confirmed in the Rajya Sabha that eleven calls for proposals had been announced under the BioE3 Policy across its six thematic areas, alongside the inauguration of the DBT-ICGEB Biofoundry in New Delhi to accelerate microbial strain development.
January 2026: Analysis of the industrial biotechnology competitive landscape highlighted Novonesis, DSM-Firmenich, and DuPont/IFF as the three dominant biosolutions platforms competing across household care, food and beverage, and animal nutrition applications.
October 2025: BASF announced it was seeking buyers for its feed enzyme business, a division with a 34-year operating history and complete intellectual property protection through 2032, with Novonesis, Cargill, and Asian feed manufacturers identified as likely acquirers.
July 2024: BASF, the Austrian Research Centre of Industrial Biotechnology, and the University of Graz co-developed a computer-assisted model to enhance enzyme efficiency, aimed at speeding the transition of new biocatalytic processes from laboratory to production scale.
June 2024: BASF announced the FUMBIO project, using the bacterium Basfia succiniciproducens to produce bio-based fumaric acid from sugar and carbon dioxide, backed by EUR 2.6 Million in funding from Germany's Federal Ministry for Education and Research.
June 2024: Danone launched its Biotech Open Platform, focused on scaling precision fermentation for sustainable ingredient and food production, partnering with Michelin, DMC Biotechnologies, and Credit Agricole on a EUR 16 Million initiative supporting the company's net-zero commitments.
Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements.
Key Questions This Report Answers
What is the current global white biotechnology market size?
Which product and application segments hold the largest share in the global white biotechnology market?
What are the key drivers of global white biotechnology market growth?
Which region dominates the global white biotechnology market and why?
How are government bioeconomy policies and biomanufacturing investment programs reshaping the industry worldwide?
Who are the top companies in the global white biotechnology market and what are their competitive strategies?
About Us
IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers create a lasting impact. The company provides a comprehensive suite of market entry and expansion services, including thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Media and Sales Contact
IMARC Group
Email: sales@imarcgroup.com
United States: +1-201-971-6302
India: +91-120-433-0800
United Kingdom: +44-753-714-6104
